Australian martial artist and Mad Max: Fury Road stunt veteran Richard Norton was 75 when he collapsed and died at his home in Melbourne in March 2025. For more than a year, the cause of his sudden death remained unclear — until Victorian Coroner David Ryan handed down findings in late October 2026 linking his fatal cardiac arrest to two injected peptides, CJC-1295 and ipamorelin. The case has turned a global spotlight on peptides, a fast-growing category of wellness injections marketed for anti-ageing, muscle growth and recovery. But what exactly are peptides, how do they work in the body, and how can an unapproved injection turn deadly?

Who Was Richard Norton and What Happened?

Richard Norton was a towering figure in martial arts and action cinema. Born in Melbourne on 6 January 1950, he built a lifelong career from his martial arts skill, first working as a bodyguard for high-profile musicians including The Rolling Stones and Linda Ronstadt. Encouraged by Ronstadt, he moved to Hollywood, where Chuck Norris gave him his first film role in The Octagon (1980). Over a career spanning more than 80 film and television projects, Norton appeared alongside Norris and Jackie Chan, and worked as a fight choreographer and stunt coordinator on productions such as Mad Max: Fury Road.

According to the coroner's findings, Norton — who had asthma, osteoarthritis and other health conditions — sought peptide therapy to address fatigue and shoulder pain. A doctor prescribed him CJC-1295 and ipamorelin, two substances that are not approved by Australia's medicines regulator, the Therapeutic Goods Administration (TGA). On 28 March 2025, two days before he died, Norton told a clinic nurse that he had been injecting double the prescribed dose, and he asked for a new script after dropping a vial. He was advised to stick to his prescription. On 30 March 2025, he injected the peptides again, suffered a severe allergic reaction known as anaphylaxis, and went into cardiac arrest.

What Exactly Are Peptides?

At the most basic level, peptides are short chains of amino acids — the same building blocks that make up proteins. While proteins are long chains, typically made of 50 or more amino acids, peptides are shorter, usually containing anywhere from two to about 50 amino acids. The difference between a peptide and a protein is largely one of length.

But peptides are far more than simple building materials. Many peptides in the human body act as signalling molecules, or chemical messengers. Think of them as tiny biological messages: a peptide binds to a specific receptor on the surface of a cell, and that binding tells the cell to do something — release a hormone, divide, contract or switch a gene on. Familiar examples include insulin, which regulates blood sugar, and oxytocin, which plays a role in bonding and childbirth. It is this signalling role that has made synthetic peptides so attractive to researchers and, increasingly, to the wellness industry.

How CJC-1295 and Ipamorelin Tell the Body to Release Growth Hormone

The two peptides injected by Richard Norton target the same system: the body's natural production of human growth hormone (HGH). Growth hormone is produced by the pituitary gland, a pea-sized gland at the base of the brain, and it helps regulate muscle and bone growth, fat metabolism and tissue repair.

In a healthy body, growth hormone release is controlled by competing signals from the hypothalamus. Growth hormone-releasing hormone (GHRH) tells the pituitary to release more growth hormone, while another hormone called somatostatin tells it to slow down. On top of this, a stomach-derived hormone called ghrelin — often called the hunger hormone — also stimulates growth hormone release.

CJC-1295 and ipamorelin are synthetic peptides designed to mimic these natural signals. CJC-1295 is an analogue of GHRH: it binds to the same GHRH receptors on the pituitary and pushes the gland to release more growth hormone. Ipamorelin is a short, five-amino-acid peptide that mimics ghrelin, binding to a receptor known as GHS-R1a to trigger an additional pulse of growth hormone. Used together — a common stack in peptide therapy — the two compounds are intended to work in a complementary way: CJC-1295 increases how much growth hormone is released per pulse, while ipamorelin increases how often those pulses occur.

In theory, this offers a gentler alternative to injecting growth hormone directly, because it nudges the body to produce its own hormone. In practice, however, neither CJC-1295 nor ipamorelin is approved by the TGA, and their long-term safety has not been established.

Why Unapproved Peptides Can Be Dangerous

The Richard Norton case highlights several layers of risk that are easy to overlook when a treatment is promoted as natural or anti-ageing.

First, there is the approval gap. In Australia, medicines must be listed on the Australian Register of Therapeutic Goods (ARTG) to be legally supplied as approved products. CJC-1295 and ipamorelin are not on the ARTG. Doctors can, in limited circumstances, prescribe unapproved or compounded medicines — often when no approved alternative exists for a patient — but these products have not been assessed by the TGA for quality, safety or effectiveness. Investigative reporting and TGA warnings have shown that unapproved peptides are widely supplied through wellness clinics and even social media.

Second, there is the risk of an allergic reaction. The coroner found that Norton's death was triggered by anaphylaxis — a severe, potentially life-threatening allergic response — after he injected the peptides. Anaphylaxis can cause the airways to swell and blood pressure to drop rapidly, and it can progress to cardiac arrest within minutes. Because unapproved peptides are not manufactured under the same quality controls as registered medicines, the exact composition and purity of each vial can vary, which can increase the risk of unexpected reactions.

Third, there is dosing risk. The coroner's findings noted that Norton had been administering double the prescribed dose, and had asked for a new script after dropping a vial. Injectable peptides are often self-administered at home, and even a relatively small deviation from a prescribed dose can change how the body responds.

In findings handed down on 28 October 2026, Coroner David Ryan concluded that Norton's death was triggered by his injection of CJC-1295 and ipamorelin, and he recommended that the TGA review the scheduling of these substances, including whether they should be restricted to a category reserved for experimental use. Norton's death is believed to be the first in Australia known to have been triggered by unapproved peptide use.

The case has renewed scrutiny of how unapproved peptides are prescribed and compounded in Australia. The TGA had already issued safety alerts and warnings about unregulated peptide products in the months before the coroner's findings, and regulators, including the Medical Board of Australia, have been preparing guidance on off-label prescribing and compounding. The coroner's recommendations are not legally binding, but they carry significant weight, and a TGA review could tighten the rules that currently allow doctors to prescribe compounds such as CJC-1295 and ipamorelin.

What This Means for Anyone Considering Peptide Therapy

Peptides are not automatically safe simply because they are made of amino acids or marketed as natural. They are biologically active signalling molecules that change how the body behaves, and their effects depend heavily on the specific peptide, the dose and how the product is made. The key points to remember:

  • Peptides are short chains of amino acids that act as chemical messengers, binding to receptors to trigger specific bodily responses.
  • CJC-1295 and ipamorelin work by stimulating the pituitary gland to release more growth hormone.
  • Neither substance is approved by Australia's TGA, meaning their quality, safety and effectiveness have not been independently verified.
  • Anaphylaxis and dosing errors are real risks, and unapproved injectables can vary in purity and composition.
  • Anyone considering peptide therapy should speak with a qualified medical professional and check whether the product is approved in their country.

Richard Norton's death is a reminder that even treatments prescribed by a doctor can carry serious risks when they fall outside the regulatory system. As regulators weigh tighter controls, the science of peptides themselves remains promising — but the way they are supplied and used matters just as much as how they work.